Campaigning to improve sepsis recognition and outcomes The Lancet Respiratory Medicine ++... ++

Campaigning to improve sepsis recognition and outcomes The Lancet Respiratory Medicine https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00121-9/fulltext?dgcid=raven_jbs_etoc_email May 2026 Volume 14Number 5p375-462, e31-e32 https://www.thelancet.com/journals/lanres/issue/vol14no5/PIIS2213-2600(26)X2004-5 Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial Prof Malcolm G Semple, PhDa,b Send email to m.g.semple@liverpool.ac.uk ∙ Chloe Donohue, BScc ∙ Laura Price, BScc ∙ Rachael Cooper, MScc ∙ Carly Vaughan, BScc ∙ Tracy Moittc ∙ et al. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00008-1/fulltext?dgcid=raven_jbs_etoc_feature_lanres Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial Prof Javier A Neyra, MDa ∙ Prof Matthieu Legrand, MDb Send email to matthieu.legrand@ucsf.edu ∙ Prof Mark A Tidswell, MDd ∙ Prof Ali Al-Khafaji, MDe ∙ Claude Galphin, MDf ∙ Ronald Rains, MDg ∙ et al. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00047-0/fulltext?dgcid=raven_jbs_etoc_feature_lanres